GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Ending Cash Position

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Ending Cash Position : $2.90 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Ending Cash Position?

60 Degrees Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 was $2.90 Mil.

60 Degrees Pharmaceuticals's quarterly Ending Cash Position stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($2.90 Mil).

60 Degrees Pharmaceuticals's annual Ending Cash Position increased from Dec. 2021 ($0.12 Mil) to Dec. 2022 ($0.27 Mil) and increased from Dec. 2022 ($0.27 Mil) to Dec. 2023 ($2.14 Mil).


60 Degrees Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals Ending Cash Position Chart

60 Degrees Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Ending Cash Position
0.19 0.12 0.27 2.14

60 Degrees Pharmaceuticals Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - 2.90

60 Degrees Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

60 Degrees Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.264+1.878
=2.14

60 Degrees Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.143+0.752
=2.90


60 Degrees Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Headlines